Invention Grant
- Patent Title: Anti-esophageal cancer compound and method of use thereof
-
Application No.: US15190367Application Date: 2016-06-23
-
Publication No.: US09655913B2Publication Date: 2017-05-23
- Inventor: Zhaoxiang Bian , Huaixue Mu , Chengyuan Lin , Jinjin Wang , Zhijun Yang , Aiping Lu , Albert Sun Chi Chan
- Applicant: Hong Kong Baptist University , Changshu HKBU Technology Company Limited
- Applicant Address: HK Hong Kong CN
- Assignee: Hong Kong Baptist University,Changshu HKBU Technology Company Limited
- Current Assignee: Hong Kong Baptist University,Changshu HKBU Technology Company Limited
- Current Assignee Address: HK Hong Kong CN
- Agency: Ware, Fressola, Maguire & Barber LLP
- Main IPC: A61K31/7048
- IPC: A61K31/7048 ; A61K36/888 ; A61K31/09 ; A61K31/341 ; A61K31/34 ; A61K9/00 ; A61K31/353
Abstract:
The present invention relates to the bioactive components with the anti-proliferative property. In particular, the invention relates to one flavonol compound isolated from the root of Lasia spinosa Linn. Thwait or chemically synthesized and its specific anticancer/antitumor activity. This invention has a specific application in treating human esophageal cancer.
Public/Granted literature
- US20170014438A1 ANTI- ESOPHAGEAL CANCER COMPOUND AND METHOD OF USE THEREOF Public/Granted day:2017-01-19
Information query
